6.
Lelovic N, Mitachi K, Yang J, Lemieux M, Ji Y, Kurosu M
. Application of Mycobacterium smegmatis as a surrogate to evaluate drug leads against Mycobacterium tuberculosis. J Antibiot (Tokyo). 2020; 73(11):780-789.
PMC: 7554168.
DOI: 10.1038/s41429-020-0320-7.
View
7.
Rustad T, Roberts D, Liao R, Sherman D
. Isolation of mycobacterial RNA. Methods Mol Biol. 2010; 465:13-21.
DOI: 10.1007/978-1-59745-207-6_2.
View
8.
Bezrukov F, Prados J, Renzoni A, Panasenko O
. MazF toxin causes alterations in Staphylococcus aureus transcriptome, translatome and proteome that underlie bacterial dormancy. Nucleic Acids Res. 2021; 49(4):2085-2101.
PMC: 7913683.
DOI: 10.1093/nar/gkaa1292.
View
9.
McKinney J, Honer zu Bentrup K, Munoz-Elias E, Miczak A, Chen B, Chan W
. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature. 2000; 406(6797):735-8.
DOI: 10.1038/35021074.
View
10.
Seaver L, Imlay J
. Alkyl hydroperoxide reductase is the primary scavenger of endogenous hydrogen peroxide in Escherichia coli. J Bacteriol. 2001; 183(24):7173-81.
PMC: 95566.
DOI: 10.1128/JB.183.24.7173-7181.2001.
View
11.
Rittershaus E, Baek S, Sassetti C
. The normalcy of dormancy: common themes in microbial quiescence. Cell Host Microbe. 2013; 13(6):643-51.
PMC: 3743100.
DOI: 10.1016/j.chom.2013.05.012.
View
12.
Chopra I, Roberts M
. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev. 2001; 65(2):232-60 ; second page, table of contents.
PMC: 99026.
DOI: 10.1128/MMBR.65.2.232-260.2001.
View
13.
Zhu L, Sharp J, Kobayashi H, Woychik N, Inouye M
. Noncognate Mycobacterium tuberculosis toxin-antitoxins can physically and functionally interact. J Biol Chem. 2010; 285(51):39732-8.
PMC: 3000954.
DOI: 10.1074/jbc.M110.163105.
View
14.
Culviner P, Laub M
. Global Analysis of the E. coli Toxin MazF Reveals Widespread Cleavage of mRNA and the Inhibition of rRNA Maturation and Ribosome Biogenesis. Mol Cell. 2018; 70(5):868-880.e10.
PMC: 8317213.
DOI: 10.1016/j.molcel.2018.04.026.
View
15.
Lipuma J, Cinege G, Bodogai M, Olah B, Kiers A, Endre G
. A vapBC-type toxin-antitoxin module of Sinorhizobium meliloti influences symbiotic efficiency and nodule senescence of Medicago sativa. Environ Microbiol. 2014; 16(12):3714-29.
DOI: 10.1111/1462-2920.12608.
View
16.
Nix D, DeVito J
. Ciprofloxacin and norfloxacin, two fluoroquinolone antimicrobials. Clin Pharm. 1987; 6(2):105-17.
View
17.
Weiss L, Stallings C
. Essential roles for Mycobacterium tuberculosis Rel beyond the production of (p)ppGpp. J Bacteriol. 2013; 195(24):5629-38.
PMC: 3889611.
DOI: 10.1128/JB.00759-13.
View
18.
Deb C, Lee C, Dubey V, Daniel J, Abomoelak B, Sirakova T
. A novel in vitro multiple-stress dormancy model for Mycobacterium tuberculosis generates a lipid-loaded, drug-tolerant, dormant pathogen. PLoS One. 2009; 4(6):e6077.
PMC: 2698117.
DOI: 10.1371/journal.pone.0006077.
View
19.
Nikitushkin V, Shleeva M, Zinin A, Trutneva K, Ostrovsky D, Kaprelyants A
. The main pigment of the dormant Mycobacterium smegmatis is porphyrin. FEMS Microbiol Lett. 2016; 363(19).
DOI: 10.1093/femsle/fnw206.
View
20.
Nurenberg-Goloub E, Tampe R
. Ribosome recycling in mRNA translation, quality control, and homeostasis. Biol Chem. 2019; 401(1):47-61.
DOI: 10.1515/hsz-2019-0279.
View